Cgpc, officially known as Chang Gung Pharmaceutical Corporation, is a prominent player in the pharmaceutical industry, headquartered in Taiwan (TW). Established in 1964, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a strong operational presence across Asia, Cgpc is renowned for its commitment to innovation and quality, particularly in the fields of biotechnology and generic pharmaceuticals. The company’s core offerings are distinguished by their rigorous adherence to international standards and a focus on patient safety. Cgpc has achieved notable recognition in the market, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to several key milestones, solidifying its reputation as a leader in the pharmaceutical sector.
How does Cgpc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Plastic production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cgpc's score of 23 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Cgpc reported total carbon emissions of approximately 15130000 kg CO2e for Scope 1, 16830000 kg CO2e for Scope 2, and 139490000 kg CO2e for Scope 3, reflecting a comprehensive approach to emissions tracking across all scopes. This data indicates a significant engagement in climate accountability, with emissions disclosed for all three scopes. Comparatively, in 2022, Cgpc's emissions were approximately 151239000 kg CO2e for Scope 1, 168141000 kg CO2e for Scope 2, and 1394848000 kg CO2e for Scope 3. The figures show a notable increase in Scope 3 emissions, suggesting a need for enhanced focus on upstream and downstream supply chain impacts. Despite the detailed emissions reporting, Cgpc has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The lack of climate pledges further highlights an area for potential improvement in their sustainability strategy. Cgpc's emissions data is sourced directly from China General Plastics Corporation, with no cascaded data from parent or related organizations. This direct reporting underscores the company's commitment to transparency in its environmental impact. Overall, while Cgpc demonstrates a robust framework for emissions reporting, the absence of reduction targets presents an opportunity for the company to enhance its climate commitments and align with industry best practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 5,066,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 9,425,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cgpc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
